Recurrent ovarian steroid cell tumor, not otherwise specified managed with debulking surgery, radiofrequency ablation, and adjuvant chemotherapy

نویسندگان

  • Jin Suk Kim
  • Seong Nam Park
  • Byoung Ryun Kim
چکیده

Steroid cell tumors, not otherwise specified, are infrequently encountered ovarian neoplasms, which constitute <0.1% of all ovarian tumors. Most of these tumors are unilateral, and almost one-third of all cases are reportedly malignant. However, because most of these tumors are diagnosed in the early stage, and do not recur or metastasize, little is known about their response to therapies such as chemotherapy or radiation. Here, we present a rare case of recurrent steroid cell tumor, not otherwise specified that showed a complete response after debulking surgery, radiofrequency ablation, and adjuvant chemotherapy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Steroid Cell Tumor of Ovary Diagnosed After Delivery; Case Report

Introduction: Steroid cell tumors (SCTs) constitute less than 0.1% of all ovarian tumors. They are divided into 3 categories according to cell of origin: Stromal Luteoma arising from stromal cells of the ovary, Leydig cell tumor arising from Leydig cells, and SCT not otherwise specified (NOS) when the origin of the tumor is not defined. Case Presentation:...

متن کامل

Narrow-band imaging in laparoscopic management of recurrent platinum sensitive ovarian cancer.

The recurrence risk for advanced ovarian cancer managed using surgical cytoreduction and adjuvant chemotherapy is 60% to 70% [1]. The standard treatment of recurrent disease is still under debate and depends on patient history and characteristics of the tumor [1,2]. Recently, the role of cytoreductive surgery for platinum-sensitive cancer has been reassessed, and findings indicate that residual...

متن کامل

7. Cytoreductive surgery in endometrial cancer and uterine sarcomas

Optimal cytoreductive surgery has an emerging therapeutic role in the management of advanced and recurrent uterine carcinomas, especially if used in conjunction with adjuvant chemotherapy and/or radiation. Theoretically, successful tumor debulking can produce fractional log kill of malignant cells while sensitizing residual nodules to adjuvant therapies, expand tumor perfusion and drug delivery...

متن کامل

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)

Ovarian cancer is the most lethal gynecological malignancy, with aggressive surgical debulking and adjuvant chemotherapy as the main treatment modalities. Optimal debulking during the primary surgery is significantly correlated with prolonged survival. As surgical techniques and chemotherapeutic agents improve, more patients with prolonged survival may face secondary and tertiary recurrences. T...

متن کامل

A Case of Ovarian Steroid Cell Tumor, Not Otherwise Specified, Treated with Surgery and Gonadotropin Releasing Hormone Agonist

Steroid cell tumors account for less than 0.1% of all ovarian tumors. There are three steroid cell tumor subtypes: steroid cell tumor not otherwise specified (NOS), stromal luteoma and Leydig cell tumor. Steroid cell tumor, NOS, is the most common type and has malignant potential. This report describes a case of an ovarian steroid cell tumor, NOS. A 35-year-old woman visited hospital with the c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 57  شماره 

صفحات  -

تاریخ انتشار 2014